Al Hammadi Holding — Capital/Financing Update 2021

Oct 10, 2021

Addendum Announcement from Al Hammadi Company for Development and Investment in regards to signing an agreement to purchase 35% of Sudair Pharmaceutical Company

4007 · 10/10/2021 09:44:42 · Announcement #65103 · View on Saudi Exchange

Addendum Announcement from Al Hammadi Company for Development and Investment in regards to signing an agreement to purchase 35% of Sudair Pharmaceutical Company

Element List	Explanation
Date of Posting the Previous Announcement of Development on Tadawul's Website	2021-07-11 Corresponding to 1442-12-01
URL of the Previous Announcement	Click Here
Change on the Development	extending the duration of the agreement for another month
Financial Impact on the change	none

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.